|
VMD-928 100 mg Tablet Clinical Trials
1 actively recruiting trial across 1 location
Also known as: Monotherapy
Santa Rosa, California1 trial
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Providence Medical Foundation (site 209)
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.